Improvement of Paclitaxel-Associated Adverse Reactions (ADRs) via the | IJN
Randomised, double-blind trial of carboplatin and paclitaxel with daily oral cediranib or placebo in patients with advanced non-small cell lung cancer: NCIC Clinical Trials Group study BR29 - European Journal of Cancer
Diagram of the study; clinical trial flow chart. A total of 100... | Download Scientific Diagram
Phase iii/iv clinical trials of albumin-bound paclitaxel (nab-P) | Download Table
FDA: Paclitaxel device clinical trials “may continue”
Phase 3 Trial Comparing Nanoparticle Albumin-Bound Paclitaxel With Docetaxel for Previously Treated Advanced NSCLC - ScienceDirect
Nab-paclitaxel versus solvent-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE): an open-label, randomised, non-inferiority, phase 3 trial - The Lancet Gastroenterology & Hepatology
Paclitaxel and Carboplatin for Carcinoma Clinical Trial | Power
Open-label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC versus the combination of paclitaxel and everolimus followed by FEC in women with triple receptor-negative breast cancer† - Annals
PLOS ONE: A First-Time-In-Human Phase I Clinical Trial of Bispecific Antibody-Targeted, Paclitaxel-Packaged Bacterial Minicells
nab-paclitaxel, paclitaxel, and docetaxel in metastatic breast cancer:... | Download Table
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial - The Lancet
Clinical Trials Included in the Meta-Analysis | Download Table
Immunotherapy as a treatment strategy in advanced stage and recurrent endometrial cancer: review of current phase III immunotherapy clinical trials - Ramez N. Eskander, Matthew A. Powell, 2021
Efficacy and safety of carboplatin with nab-paclitaxel versus docetaxel in older patients with squamous non-small-cell lung cancer (CAPITAL): a randomised, multicentre, open-label, phase 3 trial - The Lancet Healthy Longevity
Paclitaxel nanoformulations that are approved or in clinical trials for... | Download Scientific Diagram
Efficacy and safety of first-line veliparib and carboplatin–paclitaxel in patients with HER2− advanced germline BRCA+ breast cancer: Subgroup analysis of a randomised clinical trial - European Journal of Cancer
Assessment of an RNA interference screen-derived mitotic and ceramide pathway metagene as a predictor of response to neoadjuvant paclitaxel for primary triple-negative breast cancer: a retrospective analysis of five clinical trials -
.jpg "HaiHe Biopharma's Oral Paclitaxel RMX3001 Granted Clinical Trial Approval by CNDA")
HaiHe Biopharma's Oral Paclitaxel RMX3001 Granted Clinical Trial Approval by CNDA
Efficacy and safety findings from DREAM: a phase III study of DHP107 (oral paclitaxel) versus i.v. paclitaxel in patients with advanced gastric cancer after failure of first-line chemotherapy - Annals of Oncology
CIRSE 2019: Hear the latest from clinical trials comparing paclitaxel technologies head-to-head - Vascular News
![CLINICAL TRIALS [GANNET53]](http://gannet53.eu/_media/concept_of_eudario.png "CLINICAL TRIALS [GANNET53]")
CLINICAL TRIALS [GANNET53]
Efficacy and safety of a novel paclitaxel-nano-coated balloon for femoropopliteal angioplasty: one-year results of the EffPac trial - EuroIntervention
Frontiers | Targeting Strategies for Enhancing Paclitaxel Specificity in Chemotherapy | Cell and Developmental Biology
Main clinical trials with gemcitabine and nab-paclitaxel in other... | Download Table
